Cargando…
Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
BACKGROUND: Idiopathic pulmonary fibrosis is characterized by loss of lung epithelial cells and inexorable progression of fibrosis with no effective and approved treatments. The distal airway stem/progenitor cells (DASCs) have been shown to have potent regenerative capacity after lung injury. In thi...
Autores principales: | Shi, Yun, Dong, Mingqing, Zhou, Yueqing, Li, Wangping, Gao, Yongheng, Han, Luyao, Chen, Min, Lin, Hongwei, Zuo, Wei, Jin, Faguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547529/ https://www.ncbi.nlm.nih.gov/pubmed/31159891 http://dx.doi.org/10.1186/s13287-019-1257-2 |
Ejemplares similares
-
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021) -
Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Yuan, Yuan, et al.
Publicado: (2021) -
17(R)‐resolvin D1 ameliorates bleomycin‐induced pulmonary fibrosis in mice
por: Yatomi, Masakiyo, et al.
Publicado: (2015) -
Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice
por: Li, Hui, et al.
Publicado: (2017) -
Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
por: Wan, Yun-Yan, et al.
Publicado: (2013)